Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether bendamustine HCl for injection is safe and
effective in the treatment of Rituximab refractory or relapsed B-cell indolent lymphoma.